BMRN

BioMarin Pharmaceutical (BMRN)

About BioMarin Pharmaceutical (BMRN)

BioMarin Pharmaceutical, Inc. is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. The company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.

Details

Daily high

$59.27

Daily low

$58.19

Price at open

$58.82

52 Week High

$66.28

52 Week Low

$49.26

Market cap

11.3B

Dividend yield

0.00%

Volume

15,437

Avg. volume

2.0M

P/E ratio

42.79

BioMarin Pharmaceutical News